2021
DOI: 10.1101/2021.03.18.436048
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A Circuit for Secretion-coupled Cellular Autonomy in Multicellular Eukaryotes

Abstract: SUMMARYIntercellular (between-cells) signals must be converted into an intracellular (within-cell) signal before it can trigger a proportionate response. How cells mount such proportionate responses within their interior remains unknown. Here we unravel the role of a coupled GTPase circuit on the Golgi membranes which enables the intracellular secretory machinery to respond proportionately to the growth factors in the extracellular space. The circuit, comprised of two species of biological switches, the Ras-su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3
1

Relationship

3
1

Authors

Journals

citations
Cited by 4 publications
(16 citation statements)
references
References 176 publications
(369 reference statements)
0
16
0
Order By: Relevance
“…To study how autonomy in cancer cells impact cancer progression, and more specifically, breast cancers, we took the advantage of two MDA MB-231 breast cancer cell lines, that are either endowed (WT) or impaired (GIV-KO by CRISPR ( 24 )) in growth signaling autonomy ( Fig 1a ). We focused on these cells because they are a highly aggressive, invasive, and poorly differentiated triple-negative breast cancer (TNBC) cell line which lacks the estrogen receptor (ER), progesterone receptor (PR), as well as amplification of the HER2 (human epidermal growth factor receptor 2) receptor and is one of the triple-negative basal subtype cell line most widely used in metastatic breast cancer research ( 27 ) (40.2% of total PubMed citations).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…To study how autonomy in cancer cells impact cancer progression, and more specifically, breast cancers, we took the advantage of two MDA MB-231 breast cancer cell lines, that are either endowed (WT) or impaired (GIV-KO by CRISPR ( 24 )) in growth signaling autonomy ( Fig 1a ). We focused on these cells because they are a highly aggressive, invasive, and poorly differentiated triple-negative breast cancer (TNBC) cell line which lacks the estrogen receptor (ER), progesterone receptor (PR), as well as amplification of the HER2 (human epidermal growth factor receptor 2) receptor and is one of the triple-negative basal subtype cell line most widely used in metastatic breast cancer research ( 27 ) (40.2% of total PubMed citations).…”
Section: Resultsmentioning
confidence: 99%
“…We focused on these cells because they are a highly aggressive, invasive, and poorly differentiated triple-negative breast cancer (TNBC) cell line which lacks the estrogen receptor (ER), progesterone receptor (PR), as well as amplification of the HER2 (human epidermal growth factor receptor 2) receptor and is one of the triple-negative basal subtype cell line most widely used in metastatic breast cancer research ( 27 ) (40.2% of total PubMed citations). It is also a cell line that has been shown to require GIV for growth signaling autonomy ( 24 ). We analyzed these cells by functional and ‘omics’-based approaches to navigate the uncharted territory of cancer cell autonomy.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Subsequently, GIV increases the level of the GAP for mGTPase by molecular scaffolding action, and the activated tGT-Pase acts as a co-factor to maximally activate the GAP. This circuit was subsequently modeled for cell secretion (44) and for stability analysis (43).…”
Section: Model Developmentmentioning
confidence: 99%